SCHEDULE: Orbis, Allan Gray Disclose 5.8% Stake in Genmab A/S

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.8% beneficial ownership stake in Genmab A/S common stock.

Summary

• Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have filed a Schedule 13G, indicating passive beneficial ownership in Genmab A/S.
• The aggregate beneficial ownership reported by the two entities is 3,732,731 shares of Genmab A/S common stock.
• This aggregate ownership represents 5.8% of the class of securities.
• Orbis Investment Management Ltd holds 3,726,799 shares with sole voting and dispositive power.
• Allan Gray Australia Pty Ltd holds 5,932 shares with sole voting and dispositive power.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Genmab A/S.
• Both reporting persons are classified as Financial Institutions (FI), equivalent to Investment Advisers (IA).
• They are filing together but explicitly state they are not a 'group' for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of passive beneficial ownership, indicating no immediate positive or negative sentiment regarding the issuer's performance or strategic direction.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive ownership by institutional investors, which can be viewed as a vote of confidence in the company's long-term prospects.

Key Dates

Recommendation

This Schedule 13G filing indicates a passive ownership stake by two investment management firms. It does not provide new information regarding the company's operational performance, strategic initiatives, or financial health that would warrant a change in investment recommendation. The disclosure primarily serves as a transparency requirement for significant beneficial ownership, suggesting a continued 'hold' stance based solely on this filing.

Keywords

Genmab A/S, K3967W102, Schedule 13G, Beneficial Ownership, Orbis Investment Management, Allan Gray Australia, Common Stock, Investment Adviser, Passive Investment